PfizerFlex Patient Support Program for IXIFI® – Psoriatic Arthritis

About psoriatic arthritis

Psoriatic arthritis is a type of inflammatory arthritis that affects the joints and entheses (where tendons and ligaments attach to bone), leading to possible pain and joint damage. Symptoms for psoriatic arthritis usually appear between the ages of 30 to 50.

What is IXIFI used for?

IXIFI is also used in people with active psoriatic arthritis. Your doctor has chosen to treat your psoriatic arthritis with IXIFI because your disease is still active even though you have tried other treatments.

How does IXIFI work?

IXIFI is a medicine that affects your immune system necrosis factor alpha (TNF alpha). The active ingredient in IXIFI is called infliximab. Infliximab is a monoclonal antibody, a type of protein that recognizes and binds to other unique proteins. Infliximab binds to and neutralizes TNF alpha. Infliximab is made from mouse and human proteins.

IXIFI is a medicine that affects your immune system. IXIFI can lower the ability of your immune system to fight injections.

Usual dose

IXIFI will be given to you by a healthcare professional. The medicine will be given to you through a needle placed in a vein in your arm. This is called an infusion. The infusion will take about 2 hours.

During the infusion you will be monitored for side effects. You must stay for 1 to 2 hours after the infusion so that you can continue to be watched for any reactions to the medicine.

The recommended dose of IXIFI is 5 mg/kg.

Infusion 1

Infusion 2

Infusion 3

Every 8 weeks thereafter for all following infusion

If you show no response at 24 weeks, no additional treatment with IXIFI should be given.

Please refer to your patient leaflet for complete dosing instructions.

Welcome